Daiichi Sankyo is in talks with several companies over a sale of its over-the-counter (OTC) business, according to press reports.
Citing Nikkei Business, Reuters reported that the final price is likely to reach around 100 billion yen – approximately $900 million.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,